Evidence map›Paper›PMID 42564550›Full record

ArticleClinical kidney journal2026

Dialysis modality and survival in octogenarians: real-world population-based cohort study.

Néstor Toapanta, María Antonieta Azancot, Jordi Comas, Natalia Ramos, Juan León-Román, Marc Patricio-Liébana, Jorge Sánchez Olaya, Tiffany Alvarez, Efraín Tatis, Sara Nuñez and 7 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Néstor ToapantaNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5983-6863
María Antonieta AzancotNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.
Jordi ComasCatalan Transplantation Organization, Barcelona, Spain.
Natalia RamosNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-9832-326X
Juan León-RománNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-8058-1834
Marc Patricio-LiébanaNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-9669-0071
Jorge Sánchez OlayaNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.
Tiffany AlvarezNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.
Efraín TatisNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.
Sara NuñezNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-3481-2520
Natalia PadronNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.
Héctor BedoyaNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.
Iván ZamoraNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0009-0003-0423-703X
Jaume TortCatalan Transplantation Organization, Barcelona, Spain.
Oriol BestardNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-9468-7920
Francesc MoresoNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-7267-3963
María José SolerNephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-3621-0766

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evidence guiding dialysis modality decisions in very elderly patients is limited, and real-world outcomes remain poorly characterized. This study evaluates long-term survival in octogenarians initiating kidney replacement therapy (KRT) by dialysis modality. Methods: We used data from the Catalan Renal Registry to identify all patients aged ≥80 years who started dialysis between 2000 and 2022. Patients were classified according to initial dialysis modality [hemodialysis (HD) vs peritoneal dialysis (PD)]. A 1:3 propensity score-matched analysis was performed. Transition from PD to HD was modeled as a time-dependent covariate in Cox proportional hazards models to account for modality switching and minimize immortal-time bias. Results: Among 4205 octogenarians, 239 initiated PD, 3966 initiated HD. After matching, 213 PD patients were compared to 637 HD controls. Five-year survival did not differ significantly by initial modality after adjustment. However, switching from PD to HD was independently associated with increased mortality (HR 1.46; 95% CI 1.02-2.08; Conclusions: In this large population-based cohort of octogenarians, initial dialysis modality was not associated with differences in survival after adjustment. However, transition from PD to HD was associated with higher mortality, underscoring the importance of dynamic monitoring and ongoing clinical reassessment in peritoneal dialysis.

Indexed as

dialysis modalityend-stage kidney diseasehemodialysisoctogenariansperitoneal dialysispropensity score matchingsurvival analysis

Identifiers

PMID42564550
PMCPMC13444172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.